Temirak A

References (3)

Title : Hydrazone-sulfonate hybrids as potential cholinesterase inhibitors: design, synthesis and molecular modeling simulation - Omar_2023_Future.Med.Chem__
Author(s) : Omar MA , El-Shiekh RA , Dawood DH , Temirak A , Srour AM
Ref : Future Med Chem , : , 2023
Abstract : Omar_2023_Future.Med.Chem__
ESTHER : Omar_2023_Future.Med.Chem__
PubMedSearch : Omar_2023_Future.Med.Chem__
PubMedID: 37994559

Title : Therapeutic potential of 1,3,4-oxadiazoles as potential lead compounds for the treatment of Alzheimer's disease - Naseem_2023_RSC.Adv_13_17526
Author(s) : Naseem S , Temirak A , Imran A , Jalil S , Fatima S , Taslimi P , Iqbal J , Tasleem M , Tahir MN , Shafiq Z
Ref : RSC Adv , 13 :17526 , 2023
Abstract : Naseem_2023_RSC.Adv_13_17526
ESTHER : Naseem_2023_RSC.Adv_13_17526
PubMedSearch : Naseem_2023_RSC.Adv_13_17526
PubMedID: 37304812

Title : Synthesis and evaluation of novel xanthene-based thiazoles as potential antidiabetic agents - Naseem_2022_Arch.Pharm.(Weinheim)__e2200356
Author(s) : Naseem S , Shafiq Z , Taslimi P , Hussain S , Taskin-Tok T , Kisa D , Saeed A , Temirak A , Tahir MN , Rauf K , El-Gokha A
Ref : Arch Pharm (Weinheim) , :e2200356 , 2022
Abstract : Naseem_2022_Arch.Pharm.(Weinheim)__e2200356
ESTHER : Naseem_2022_Arch.Pharm.(Weinheim)__e2200356
PubMedSearch : Naseem_2022_Arch.Pharm.(Weinheim)__e2200356
PubMedID: 36220614